Lisinopril Supplier-Buyer Network — Trade Flow Analysis

Name: Lisinopril Supplier-Buyer Trade Network Dataset — 221+ Indian Exporters, 14+ Importers, 94+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Lisinopril supplier network, Lisinopril buyers, pharmaceutical export India, Lisinopril trade data

TransData Nexus

Lisinopril

India Pharmaceutical Trade Intelligence

$60.4M221 Suppliers94 CountriesHS 30049071

ExportsIndia → NETHERLANDS42.6%India → UNITED STATES25.0%

ImportsCANADA → India$801.3K BULGARIA → India$278.2K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN B,V,

Who Supplies Lisinopril? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Lisinopril exporter from India, with a market share of 42.1% and a total export value of $25.5M across 16 shipments. Their average shipment value of $1.6M is above the market average of $17.2K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN B,V, is the dominant customer, accounting for 76.8% of this supplier's tracked business. Top customers include:

• MYLAN B,V, — $19.6M across 12 shipments (76.8% of this supplier's total exports)

• MYLAN IRELAND C/O ALLOGA RDC, — $5.0M across 3 shipments (19.6% of this supplier's total exports)

• MYLAN B,V C/0 TJOAPA — $898.1K across 1 shipments (3.5% of this supplier's total exports)

• MYLAN IRELAND C/O ALLOGA RDC, — $11.4K across 0 shipments (0.0% of this supplier's total exports)

• MYLAN B,V, — $8.5K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $1.6M is 9155% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.

2LUPIN LIMITED

LUPIN LIMITED is the second-largest Lisinopril exporter from India, with a market share of 23.1% and a total export value of $13.9M across 86 shipments. Their average shipment value of $162.2K is above the market average of $17.2K, suggesting premium or bulk contract pricing.

LUPIN LIMITED serves 5 named buyers in our database. LUPIN PHARMACEUTICALS INC is the dominant customer, accounting for 57.0% of this supplier's tracked business. Top customers include:

• LUPIN PHARMACEUTICALS INC — $7.9M across 49 shipments (57.0% of this supplier's total exports)

• XXPINXXHARXXCEUXXCALXXINC — $4.2M across 26 shipments (30.1% of this supplier's total exports)

• XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX — $828.0K across 5 shipments (5.9% of this supplier's total exports)

• LUPIN PHARMACEUTICALS INC — $656.7K across 4 shipments (4.7% of this supplier's total exports)

• XXPINXXHARXXCEUXXCALXXINC — $315.0K across 2 shipments (2.3% of this supplier's total exports)

Key Insight: LUPIN LIMITED's per-shipment value of $162.2K is 843% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.

3MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the third-largest Lisinopril exporter from India, with a market share of 3.1% and a total export value of $1.9M across 3 shipments. Their average shipment value of $631.5K is above the market average of $17.2K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 1 named buyer in our database. FORTRESS PHARMACEUTI is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• FORTRESS PHARMACEUTI — $1.9M across 3 shipments (100.0% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $631.5K is 3572% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.

4STALLION LABORATORIES PRIVATE LIMITED

STALLION LABORATORIES PRIVATE LIMITED is the fourth-largest Lisinopril exporter from India, with a market share of 3.1% and a total export value of $1.9M across 6 shipments. Their average shipment value of $309.9K is above the market average of $17.2K, suggesting premium or bulk contract pricing.

STALLION LABORATORIES PRIVATE LIMITED serves 1 named buyer in our database. To The Order is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• To The Order — $1.9M across 6 shipments (100.0% of this supplier's total exports)

Key Insight: STALLION LABORATORIES PRIVATE LIMITED's per-shipment value of $309.9K is 1702% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.

5IPCA LABORATORIES LIMITED

IPCA LABORATORIES LIMITED is the fifth-largest Lisinopril exporter from India, with a market share of 2.7% and a total export value of $1.6M across 418 shipments. Their average shipment value of $3.9K is below the market average of $17.2K, reflecting a high-volume, competitive pricing strategy.

IPCA LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• NA — $775.6K across 200 shipments (47.8% of this supplier's total exports)

• VITPHARMA MARKET — $289.4K across 75 shipments (17.8% of this supplier's total exports)

• TO THE ORDER — $273.8K across 71 shipments (16.9% of this supplier's total exports)

• ZYFAS PHARMA PTE LTD — $182.4K across 47 shipments (11.2% of this supplier's total exports)

• STREET AUCKLAND CENT — $101.2K across 26 shipments (6.2% of this supplier's total exports)

Key Insight: IPCA LABORATORIES LIMITED operates with high shipment frequency (418 shipments) at a per-shipment value of $3.9K, indicating a broad distribution network with many smaller, regular orders.

6MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Lisinopril exporter from India, with a market share of 2.4% and a total export value of $1.4M across 50 shipments. Their average shipment value of $28.5K is above the market average of $17.2K, suggesting premium or bulk contract pricing.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BROWN AND BURK UK LIMITED — $616.7K across 22 shipments (43.3% of this supplier's total exports)

• HAWKARY PHARMACEUTICAL COMPANY# — $481.2K across 17 shipments (33.8% of this supplier's total exports)

• HAWKARY PHARMACEUTICAL COMPANY# — $171.7K across 6 shipments (12.0% of this supplier's total exports)

• OOO "LIFE CELL" LTD — $93.5K across 3 shipments (6.6% of this supplier's total exports)

• DA NANG PHARMACEUTIC — $62.2K across 2 shipments (4.4% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED's per-shipment value of $28.5K is 66% above the market average of $17.2K, consistent with large-order contracts or value-added formulations.

1Netherlands

Netherlands ranks as the first-largest destination for Lisinopril imports from India, with a total trade value of $25.8M across 5 shipments — representing a 42.6% share of all Lisinopril exports. The average shipment value of $5.2M is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Lisinopril importers in Netherlands: MYLAN B,V, is the largest buyer, accounting for 75.9% ($19.6M) of this market's total imports.

• MYLAN B,V, — $19.6M (75.9% of Netherlands's total)

• MYLAN IRELAND C/O ALLOGA RDC, — $5.0M (19.4% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $5.2M (29874% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Lisinopril imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Lisinopril imports from India, with a total trade value of $15.1M across 64 shipments — representing a 25.0% share of all Lisinopril exports. The average shipment value of $235.7K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Lisinopril importers in United States: LUPIN PHARMACEUTICAL INC is the largest buyer, accounting for 52.7% ($7.9M) of this market's total imports.

• LUPIN PHARMACEUTICAL INC — $7.9M (52.7% of United States's total)

• XXPINXXHARXXCEUXXCALXXINC — $4.2M (27.8% of United States's total)

• XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX — $828.0K (5.5% of United States's total)

Key Insight: United States's per-shipment average of $235.7K (1271% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Lisinopril imports from India.

Primary Market

Secondary Market

3Nigeria

Nigeria ranks as the third-largest destination for Lisinopril imports from India, with a total trade value of $3.7M across 0 shipments — representing a 6.1% share of all Lisinopril exports. The average shipment value of $3.7M is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Nigeria's per-shipment average of $3.7M (21371% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Lisinopril imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Lisinopril imports from India, with a total trade value of $2.3M across 34 shipments — representing a 3.8% share of all Lisinopril exports. The average shipment value of $67.4K is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Lisinopril importers in United Kingdom: BROWN AND BURK UK LIMITED is the largest buyer, accounting for 37.2% ($852.4K) of this market's total imports.

• BROWN AND BURK UK LIMITED — $852.4K (37.2% of United Kingdom's total)

• RELONCHEM LTD — $345.8K (15.1% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $67.4K (292% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Lisinopril imports from India.

Primary Market

Secondary Market

5Georgia

Georgia ranks as the fifth-largest destination for Lisinopril imports from India, with a total trade value of $2.1M across 0 shipments — representing a 3.5% share of all Lisinopril exports. The average shipment value of $2.1M is above the global average of $17.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: Georgia's per-shipment average of $2.1M (12146% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Georgia is a key market for Lisinopril imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lisinopril.
2.Flow Mapping: 221 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,514 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 94 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,514 Verified Shipments

221 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Lisinopril

Lisinopril

Who Supplies Lisinopril? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Lisinopril? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Lisinopril Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2LUPIN LIMITED

3MACLEODS PHARMACEUTICALS LTD

4STALLION LABORATORIES PRIVATE LIMITED

5IPCA LABORATORIES LIMITED

6MICRO LABS LIMITED

From Indian Factories to Global Pharmacies — How Lisinopril Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Lisinopril Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

2United States

3Nigeria

4United Kingdom

5Georgia

People Also Ask — Lisinopril Supplier & Trade Network

Lisinopril Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology